BridgePoint nets CE Mark for CTO crossing, re-entry systems

Justine Varieur Cadet | | Health Imaging | Diagnostic Imaging
BridgePoint Medical has received CE Mark for its coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO crossing catheter and the Stingray CTO re-entry system.

According to the Minneapolis-based company, the BridgePoint System is a series of interventional catheters that are designed to navigate diseased arteries, in preparation for blood flow restoration via angioplasty and stenting.

The disposable CrossBoss and the Stingray are indicated in the European Union for adults with coronary or peripheral artery disease, age 18 and older. The devices are contraindicated for use in cerebral vasculature.

Justine Varieur Cadet

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.